Floyd Robert Michael 4
4 · Processa Pharmaceuticals, Inc. · Filed Feb 10, 2023
Insider Transaction Report
Form 4
Floyd Robert Michael
Chief Operating Officer
Transactions
- Award
Common Stock
2023-02-09$0.80/sh+10,000$8,000→ 82,267 total
Holdings
- 89,794(indirect: by Elion Oncology, Inc.)
Common Stock